Nuvation Bio (NUVB) is trading 2% higher Friday morning after Cantor Fitzgerald initiated the stock at overweight, saying that the Street is undervaluing its sole marketed therapy and its lead candidate. – The firm did not set a price target. – Nuvation’s
Rises Nuvation Bio as Cantor Initiates at Overweight
Nuvation Bio (NUVB) is trading 2% higher Friday morning after Cantor Fitzgerald initiated the stock at overweight, saying that the Street is undervaluing its sole marketed therapy and its lead candidate. - The firm did not set a price target. - Nuvation's